vs

Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and Xeris Biopharma Holdings, Inc. (XERS). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $85.8M, roughly 1.2× Xeris Biopharma Holdings, Inc.). Xeris Biopharma Holdings, Inc. runs the higher net margin — 12.9% vs 11.6%, a 1.3% gap on every dollar of revenue. On growth, Xeris Biopharma Holdings, Inc. posted the faster year-over-year revenue change (42.8% vs 8.0%). Over the past eight quarters, Xeris Biopharma Holdings, Inc.'s revenue compounded faster (45.3% CAGR vs 1.0%).

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

Xeris Biopharma Holdings, Inc. is a specialty biopharmaceutical company that develops and commercializes targeted therapies for rare endocrine, metabolic, and dermatological conditions. It operates across global markets, focusing on delivering accessible, easy-to-administer treatment options for underserved patient segments.

CSV vs XERS — Head-to-Head

Bigger by revenue
CSV
CSV
1.2× larger
CSV
$105.5M
$85.8M
XERS
Growing faster (revenue YoY)
XERS
XERS
+34.8% gap
XERS
42.8%
8.0%
CSV
Higher net margin
XERS
XERS
1.3% more per $
XERS
12.9%
11.6%
CSV
Faster 2-yr revenue CAGR
XERS
XERS
Annualised
XERS
45.3%
1.0%
CSV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSV
CSV
XERS
XERS
Revenue
$105.5M
$85.8M
Net Profit
$12.3M
$11.1M
Gross Margin
34.8%
Operating Margin
23.3%
19.5%
Net Margin
11.6%
12.9%
Revenue YoY
8.0%
42.8%
Net Profit YoY
24.5%
316.7%
EPS (diluted)
$0.76
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSV
CSV
XERS
XERS
Q4 25
$105.5M
$85.8M
Q3 25
$102.7M
$74.4M
Q2 25
$102.1M
$71.5M
Q1 25
$107.1M
$60.1M
Q4 24
$97.7M
$60.1M
Q3 24
$100.7M
$54.3M
Q2 24
$102.3M
$48.1M
Q1 24
$103.5M
$40.6M
Net Profit
CSV
CSV
XERS
XERS
Q4 25
$12.3M
$11.1M
Q3 25
$6.6M
$621.0K
Q2 25
$11.7M
$-1.9M
Q1 25
$20.9M
$-9.2M
Q4 24
$9.9M
$-5.1M
Q3 24
$9.9M
$-15.7M
Q2 24
$6.3M
$-15.0M
Q1 24
$7.0M
$-19.0M
Gross Margin
CSV
CSV
XERS
XERS
Q4 25
34.8%
Q3 25
35.3%
Q2 25
35.2%
Q1 25
35.3%
Q4 24
34.4%
Q3 24
35.2%
Q2 24
36.2%
Q1 24
36.0%
Operating Margin
CSV
CSV
XERS
XERS
Q4 25
23.3%
19.5%
Q3 25
17.0%
9.0%
Q2 25
23.5%
6.3%
Q1 25
29.5%
-5.1%
Q4 24
21.6%
2.8%
Q3 24
22.7%
-23.8%
Q2 24
18.0%
-17.0%
Q1 24
18.8%
-35.1%
Net Margin
CSV
CSV
XERS
XERS
Q4 25
11.6%
12.9%
Q3 25
6.4%
0.8%
Q2 25
11.5%
-2.7%
Q1 25
19.5%
-15.3%
Q4 24
10.1%
-8.5%
Q3 24
9.8%
-29.0%
Q2 24
6.1%
-31.2%
Q1 24
6.7%
-46.7%
EPS (diluted)
CSV
CSV
XERS
XERS
Q4 25
$0.76
$0.07
Q3 25
$0.41
$0.00
Q2 25
$0.74
$-0.01
Q1 25
$1.34
$-0.06
Q4 24
$0.62
$-0.02
Q3 24
$0.63
$-0.11
Q2 24
$0.40
$-0.10
Q1 24
$0.45
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSV
CSV
XERS
XERS
Cash + ST InvestmentsLiquidity on hand
$1.7M
$111.0M
Total DebtLower is stronger
$220.3M
Stockholders' EquityBook value
$254.8M
$13.7M
Total Assets
$1.3B
$383.5M
Debt / EquityLower = less leverage
16.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSV
CSV
XERS
XERS
Q4 25
$1.7M
$111.0M
Q3 25
$1.2M
$91.6M
Q2 25
$1.4M
$59.3M
Q1 25
$4.6M
$58.4M
Q4 24
$1.2M
$71.6M
Q3 24
$1.3M
$69.4M
Q2 24
$1.5M
$77.6M
Q1 24
$1.7M
$87.4M
Total Debt
CSV
CSV
XERS
XERS
Q4 25
$220.3M
Q3 25
$219.5M
Q2 25
$218.6M
Q1 25
$229.8M
Q4 24
$232.1M
Q3 24
$216.2M
Q2 24
$230.5M
Q1 24
$229.7M
Stockholders' Equity
CSV
CSV
XERS
XERS
Q4 25
$254.8M
$13.7M
Q3 25
$242.1M
$-861.0K
Q2 25
$235.4M
$-19.3M
Q1 25
$223.1M
$-35.1M
Q4 24
$208.6M
$-29.6M
Q3 24
$198.1M
$-28.3M
Q2 24
$187.9M
$-19.3M
Q1 24
$179.6M
$-9.2M
Total Assets
CSV
CSV
XERS
XERS
Q4 25
$1.3B
$383.5M
Q3 25
$1.3B
$370.2M
Q2 25
$1.3B
$334.7M
Q1 25
$1.3B
$315.5M
Q4 24
$1.3B
$323.1M
Q3 24
$1.3B
$321.1M
Q2 24
$1.3B
$331.7M
Q1 24
$1.3B
$336.6M
Debt / Equity
CSV
CSV
XERS
XERS
Q4 25
16.10×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSV
CSV
XERS
XERS
Operating Cash FlowLast quarter
$14.1M
$20.0M
Free Cash FlowOCF − Capex
$6.2M
FCF MarginFCF / Revenue
5.9%
Capex IntensityCapex / Revenue
7.5%
Cash ConversionOCF / Net Profit
1.15×
1.81×
TTM Free Cash FlowTrailing 4 quarters
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSV
CSV
XERS
XERS
Q4 25
$14.1M
$20.0M
Q3 25
$24.7M
$18.4M
Q2 25
$8.1M
$182.0K
Q1 25
$13.8M
$-10.0M
Q4 24
$9.3M
$2.0M
Q3 24
$20.9M
$-8.3M
Q2 24
$2.2M
$-10.3M
Q1 24
$19.7M
$-20.3M
Free Cash Flow
CSV
CSV
XERS
XERS
Q4 25
$6.2M
Q3 25
$18.0M
Q2 25
$5.2M
Q1 25
$10.6M
Q4 24
$4.9M
Q3 24
$16.2M
Q2 24
$-1.4M
Q1 24
$16.2M
FCF Margin
CSV
CSV
XERS
XERS
Q4 25
5.9%
Q3 25
17.5%
Q2 25
5.1%
Q1 25
9.9%
Q4 24
5.0%
Q3 24
16.1%
Q2 24
-1.4%
Q1 24
15.6%
Capex Intensity
CSV
CSV
XERS
XERS
Q4 25
7.5%
Q3 25
6.5%
Q2 25
2.8%
Q1 25
3.0%
Q4 24
4.5%
Q3 24
4.6%
Q2 24
3.5%
Q1 24
3.4%
Cash Conversion
CSV
CSV
XERS
XERS
Q4 25
1.15×
1.81×
Q3 25
3.76×
29.68×
Q2 25
0.69×
Q1 25
0.66×
Q4 24
0.94×
Q3 24
2.11×
Q2 24
0.34×
Q1 24
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

XERS
XERS

Products$83.4M97%
Other$2.4M3%

Related Comparisons